当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Systematic Review of Medical Nutrition Therapy and Management of High-Risk Pregnant Women

Benedict Godwin

Women who have been diagnosed with gestational diabetes mellitus (GDM) continue to face a significant risk of developing type 2 diabetes later in life. Medical nutrition therapy (MNT)'s effectiveness in treating GDM is increasingly being recognized. 488 GDM cases were studied in a retrospective cohort study. From 2008 to 2012, the pregnancy weight, changes in pregnancy weight, glucose levels, GDM management, follow-up, and birth outcomes were recorded. From 2008 to 2012, the percentage of women receiving MNT increased to 62.91 percent. The MNT group had lower fasting plasma glucose, 2-hour blood glucose, and intrapartum weight gain as well as weight gain at 28 weeks, 32 weeks, and 36 weeks. The MNT group had lower rates of adverse pregnancy events and total pregnancy weight gain (all p 0.05) than the non-MNT group. Besides, 92.2% of the members in the MNT bunch had an ordinary oral glucose resilience test result, and the pace of elite breastfeeding in something like 4 months after conveyance was 54.4% in the MNT bunch; both were higher than in the group without MNT.